Q32 Bio Advances Clinical Trials Amidst Financial Challenges

TipRanksNov 8 14:14

Q32 Bio Inc Grapples With Internal Control Challenges Amid Compliance Costs

TipRanksNov 8 14:00

Express News | Q32 Bio Inc : Piper Sandler Raises Target Price to $85 From $60

BreakingsNov 7 22:14

Q32 Bio | 10-Q: Quarterly report

SECNov 7 20:23 · Announcements

Q32 Bio Q3 2024 GAAP EPS $(1.46) Misses $(1.31) Estimate, Cash And Cash Equivalents Of $89.1M As Of September 30, 2024 Expected To Provide Financial Runway Into Mid-2026

BenzingaNov 7 20:23

Q32 Bio: Q3 Earnings Snapshot

Yahoo FinanceNov 7 20:10